title: Calcium kinetics are altered in clinically stable girls with cystic fibrosis.
abstract: Reduced bone mass in individuals with cystic fibrosis (CF) may result from alterations in calcium metabolism. Bone calcium deposition and resorption rates, calcium balance, and markers of bone turnover were assessed using stable isotopes of calcium in 22 prepubertal and pubertal girls with CF. Bone calcium deposition was associated with the availability of dietary calcium, total serum osteocalcin, and leptin concentrations. Reduced bone mass in individuals with CF may result from inadequate bone calcium (Ca) deposition, and excessive resorption, although these parameters have not been directly assessed in children with CF. We used stable Ca isotopes to measure rates of bone Ca deposition (Vo+), resorption, and retention in 22 clinically stable girls with CF (aged 7-18 yr). Rates of bone Ca deposition were determined by mathematically modeling the disappearance of iv Ca stable isotope ((42)Ca) for 6 d post dosing. Indirect markers of bone turnover and hormones associated with pubertal development were also assessed. Rates of bone Ca deposition and retention were highest during early puberty (Tanner stages 2 and 3). Calcium deposition rates in prepubertal (Tanner 1) and postmenarchal girls (Tanner stages 4 and 5) did not support substantial bone Ca retention. Net absorption of dietary Ca and serum osteocalcin and leptin concentrations were positively associated with Vo+. Time post menarche and serum leptin concentrations explained 91% of the variability in Vo+ (P = 0.0007). Serum total osteocalcin was low (10.9 +/- 5.4 ng/ml), and a substantial percentage of osteocalcin was undercarboxylated (54.3 +/- 11.8%). We concluded that increased calcium absorption and serum leptin concentrations were significantly associated with rates of bone Ca deposition, demonstrating an impact of nutritional status on this process. Rates of bone Ca deposition were lower than typically reported in healthy children, as were indirect markers of bone formation. These alterations in bone turnover contribute to reduced bone mass in girls with CF.
authors.affiliation: Center for Human Nutrition, The Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
authors.forename: Kerry J
authors.initials: KJ
authors.lastname: Schulze
authors.forename: Kimberly O
authors.initials: KO
authors.lastname: O'Brien
authors.forename: Emily L
authors.initials: EL
authors.lastname: Germain-Lee
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Booth
authors.forename: Amanda
authors.initials: A
authors.lastname: Leonard
authors.forename: Beryl J
authors.initials: BJ
authors.lastname: Rosenstein
mesh_terms: D000042:Absorption; D000293:Adolescent; D016723:Bone Remodeling; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002136:Calcium, Dietary / Q000493:pharmacokinetics*; D002648:Child; D003550:Cystic Fibrosis / Q000378:metabolism*; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood; D008572:Menarche / Q000378:metabolism; D015675:Osteocalcin / Q000097:blood; D013997:Time Factors
chemical_list: D002136:Calcium, Dietary; D020738:Leptin; D015675:Osteocalcin; D002118:Calcium